Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Journal of the American Medical Association (JAMA)

• Publication date

  2002-09-25

• Fields of study

  Medicine

• Identifiers
  DOI 10.1001/JAMA.288.12.1475PMID 12243634
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cholinesterase Inhibitors for Alzheimer’s Disease

  2012cited by this paper
• Prevalence and classification of mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 1.

  2003cited by this paper
• Evaluation of Dementia in the Cardiovascular Health Cognition Study

  2003cited by this paper
• Provisional diagnostic criteria for depression of Alzheimer disease.

  2002cited by this paper
• Clinical and cost-effectiveness of donepezil, rivastigmine and galantamine for Alzheimer's disease: a rapid and systematic review.

  2001cited by this paper
• Placebo-controlled study of divalproex sodium for agitation in dementia.

  2001cited by this paper
• An evidence‐based proposal for the classification of neuropsychiatric disturbance in Alzheimer's disease

  2001cited by this paper
• Mild cognitive impairment represents early-stage Alzheimer disease.

  2001cited by this paper
• National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE): Alzheimer disease trial methodology.

  2001cited by this paper
• A 5-month, randomized, placebo-controlled trial of galantamine in AD

  2000cited by this paper
• The detection of dementia in the primary care setting.

  2000cited by this paper
• Quality of life in dementia patients in long‐term care

  2000cited by this paper
• Olanzapine treatment of psychotic and behavioral symptoms in patients with Alzheimer disease in nursing care facilities: a double-blind, randomized, placebo-controlled trial. The HGEU Study Group.

  2000cited by this paper
• Mental and behavioral disturbances in dementia: findings from the Cache County Study on Memory in Aging.

  2000cited by this paper
• Psychosis of Alzheimer's disease and related dementias. Diagnostic criteria for a distinct syndrome.

  2000cited by this paper
• Randomized, placebo-controlled, double-blind clinical trial of sertraline in the treatment of depression complicating Alzheimer's disease: initial results from the Depression in Alzheimer's Disease study.

  2000cited by this paper
• Practical Dementia Care

  1999influential reference
• The stress and psychological morbidity of the Alzheimer patient caregiver

  1999cited by this paper
• Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial. Risperidone Study Group.

  1999cited by this paper
• A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia

  1999cited by this paper
• Wandering behaviour in community‐residing persons with dementia

  1999cited by this paper
• Dopamine receptor genetic variation, psychosis, and aggression in Alzheimer disease.

  1998cited by this paper
• Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset.

  1998cited by this paper
• A randomized, placebo-controlled dose-comparison trial of haloperidol for psychosis and disruptive behaviors in Alzheimer's disease.

  1998cited by this paper
• Efficacy and tolerability of carbamazepine for agitation and aggression in dementia.

  1998cited by this paper
• Behavioral treatment of depression in dementia patients: a controlled clinical trial.

  1997cited by this paper
• Behavioral and psychological signs and symptoms of dementia: a consensus statement on current knowledge and implications for research and treatment

  1997cited by this paper
• Predicting time to nursing home care and death in individuals with Alzheimer disease.

  1997cited by this paper
• Major and minor depression in Alzheimer's disease: prevalence and impact.

  1997cited by this paper
• A double-blind placebo-controlled study of clomipramine in depressed patients with Alzheimer's disease.

  1996cited by this paper
• Physical aggression is associated with preservation of substantia nigra pars compacta in Alzheimer disease.

  1996cited by this paper
• Moclobemide in Elderly Patients with Cognitive Decline and Depression: An International Double-blind, Placebo-controlled Trial

  1996cited by this paper
• Surveillance and ascertainment of cardiovascular events. The Cardiovascular Health Study.

  1995cited by this paper
• Low‐Dose Propranolol Reduces Aggression and Agitation Resembling That Associated with Orbitofrontal Dysfunction in Elderly Demented Patients

  1995cited by this paper
• Mania in Alzheimer's disease.

  1995cited by this paper
• Magnetic Resonance Abnormalities and Cardiovascular Disease in Older Adults: The Cardiovascular Health Study

  1994cited by this paper
• Cholinesterase Inhibitors in Alzheimer's Disease

  1994cited by this paper
• A validation study of the Dementia Questionnaire.

  1994cited by this paper
• A SPECT study of delusions in Alzheimer's disease

  1994cited by this paper
• The Neuropsychiatric Inventory

  1994cited by this paper
• Recruitment of adults 65 years and older as participants in the Cardiovascular Health Study.

  1993cited by this paper
• Clinical and neuropathological correlates of depression in Alzheimer's disease

  1992cited by this paper
• Serotonergic pathology is not widespread in Alzheimer patients without prominent aggressive symptoms

  1992cited by this paper
• A controlled multicenter clinical study of citalopram and placebo in elderly depressed patients with and without concomitant dementia

  1992cited by this paper
• The Cardiovascular Health Study: design and rationale.

  1991cited by this paper
• Neuropathologic and neurochemical correlates of psychosis in primary dementia.

  1991cited by this paper
• Psychiatric Phenomena in Alzheimer's Disease. IV: Disorders of Behaviour

  1990cited by this paper
• Psychiatric Phenomena in Alzheimer's Disease. I: Disorders of Thought Content

  1990cited by this paper
• Psychiatric Phenomena in Alzheimer's Disease. III: Disorders of Mood

  1990cited by this paper
• Neurochemical correlates of major depression in primary dementia.

  1990cited by this paper
• Psychiatric Phenomena in Alzheimer's Disease. II: Disorders of Perception

  1990cited by this paper
• Psychiatric symptoms and nursing home placement of patients with Alzheimer's disease.

  1990cited by this paper
• The neuropathology of aminergic nuclei in Alzheimer's disease.

  1988cited by this paper
• The neuropathology of aminergic nuclei in Alzheimer's disease

  1988cited by this paper
• Assessment of Cognitive Decline in the Elderly by Informant Interview

  1988cited by this paper
• The Modified Mini-Mental State (3MS) examination.

  1987cited by this paper
• Clinical diagnosis of Alzheimer's disease

  1984cited by this paper

• Apathy and Depression Impact on Cognitive Decline: Neuropsychological Specificities across Neurodegenerative Diseases

  2026cites this paper
• The Palliative Care Paradox: Investigating Unexpected Outcomes in Dementia Care.

  2026cites this paper
• Language biomarker screening using AI: a transdiagnostic approach to the brain

  2026cites this paper
• A scoping review of emotion and non-cognitive measures of decision-making ability in older adults by the ARMCADA study.

  2026cites this paper
• Neuropsychiatric Symptoms in Patients With Pathologically Confirmed Comorbid Alzheimer Disease and Frontotemporal Lobar Degeneration.

  2026cites this paper
• Effect of tau burden and Lewy pathology on neuropsychiatric symptoms in Aβ‐positive individuals

  2026cites this paper
• Neuropsychiatric symptoms in Alzheimer's disease: Past, present, and future

  2026cites this paper
• Genetic and Hormonal Contributions to Psychosis Symptoms in Alzheimer’s Disease: A Sex-Stratified Analysis

  2026cites this paper
• From mild behavioral impairment-checklist (MBI-C) to MBI-distress (MBI-D): a paired assessment and clinical correlates of domain-specific caregiver distress in MCI due to AD

  2026cites this paper
• Association between amyloid-β42 levels and neuropsychiatric symptoms in Alzheimer’s disease trials

  2025cites this paper
• Mild behavioral impairment as a predictor of cognitive decline in old age

  2025cites this paper
• Omics-AD—A multimodal biomarker study on cognitive decline and neuropsychiatric symptoms: Design and cohort characteristics

  2025cites this paper
• Neuropsychiatric symptoms and neuroimaging‐based brain age in mild cognitive impairment and early dementia: A multicenter study

  2025cites this paper
• Clinical Aspects of Mental Imagery in Alzheimer’s Disease-Related Dementia: A Review of Cognitive, Motor, and Emotional Interventions

  2025cites this paper
• Pharmacologic reversal of advanced Alzheimer’s disease in mice and identification of potential therapeutic nodes in human brain

  2025cites this paper
• Prevalence of subthreshold depression among older adults with mild cognitive impairment: a systematic review and meta-analysis.

  2025cites this paper
• Abnormal behaviors and glial responses in an animal model of tau pathology

  2025cites this paper
• Associations between traumatic brain injury and the prevalence of Alzheimer’s disease dementia and behavioral and psychological symptoms of dementia: A retrospective cohort study

  2025cites this paper
• Trends of antipsychotic prescribing for people with dementia in Spain

  2025cites this paper
• Is Hearing Impairment Associated With Specific Behavioural and Psychological Symptoms of Dementia in Japanese Older Adults Attending a Memory Clinic?

  2025cites this paper
• Systematic Review of Dementia Risk Screening Tools in Primary Care Settings.

  2025cites this paper
• RadioMe: an automated home-based radio, music playlist, and diary reminder system: Report on recruitment, music compilation, and listening, and preliminary testing of heart rate activated music

  2025cites this paper
• Kognitiivisesti painottunut monimuotoinen kuntoutus kohentaa muistisairaan mielialaa ja tukee läheisen jaksamista

  2025cites this paper
• Critical evaluation of real‐world evidence of repurposable medicines in the Alzheimer's disease drug development pipeline using a target trial emulation

  2025cites this paper
• Mechanistic study of Alzheimer's disease with behavioral and psychological symptoms based on electroencephalography microstates

  2025cites this paper
• Population-scale cross-disorder atlas of the human prefrontal cortex at single-cell resolution

  2025cites this paper
• Predicting cognitive decline from neuropsychiatric symptoms and Alzheimer's disease biomarkers: A machine learning approach to a population-based data

  2025cites this paper
• Neuropsychiatric symptoms predict rate of change in executive function in Alzheimer's disease and related dementias.

  2025cites this paper
• A bibliometric analysis of research on dementia comorbid with depression from 2005 to 2024

  2025cites this paper
• Structural Neuroimaging Correlates of Neuropsychiatric Symptoms in Alzheimer’s Disease: A Systematic Literature Review

  2025cites this paper
• Cognitive dysfunction—an under looked avenue to promote health in incarcerated elderly population through yoga

  2025cites this paper
• A Review on Modifiable Risk Factors and Preventive Measures in Alzheimer's Disease

  2025cites this paper
• In vivo-measured Lewy body pathology is associated with neuropsychiatric symptoms across the Alzheimer’s disease continuum

  2025cites this paper
• The prevalence of mild behavioral impairment in older adults with mild cognitive impairment: A systematic review and meta-analysis

  2025cites this paper
• Prevalence and predictors of metabolic syndrome among psychiatric patients receiving antipsychotic treatment in Africa: a systematic review and meta-analysis

  2025cites this paper
• Obesity and Alzheimer's disease dementia: Examining inflammatory links to cognitive decline and neuropsychiatric symptoms

  2025cites this paper
• Comparative efficacy, tolerability, and acceptability of aducanumab, lecanemab, and donanemab with repetitive transcranial magnetic stimulation on cognitive function in mild cognitive impairment and Alzheimer’s disease: A systematic review and network meta-analysis

  2025influential citation
• Validation of the Mild Behavioral Impairment Scale (MBI-S) for brief self-assessment of Mild Behavioral Impairment in people without dementia

  2025cites this paper
• Kv1.1 channel dysfunction in parvalbumin-positive interneurons contributes to anxiety-like behaviors in young adult presenilin 1/2 conditional double knockout mice

  2025cites this paper
• Exploring the Protective Effect of Marital Status on Episodic and Semantic Memory in Community-Dwelling Older Adults

  2025cites this paper
• Late‐life emergence of neuropsychiatric symptoms and risk of cognitive impairment in cognitively unimpaired individuals

  2025cites this paper
• Deterioration of Lexical Processing in Older Chinese Adults With Alzheimer's Disease: Insights From Reading Chinese Compounds.

  2025cites this paper
• Current and Emerging Pharmacological Approaches to Agitation in Alzheimer’s Disease: A Narrative Review of New and Repurposed Therapies

  2025cites this paper
• Longitudinal changes in the brain‐age gap in mild cognitive impairment and their relationships with neuropsychological functions and Alzheimer's disease biomarkers

  2025cites this paper
• Sleep Disorders in Neurodegenerative Diseases with Dementia: A Comprehensive Review

  2025cites this paper
• Prevalence and risk factors for depressive symptoms in older adults with preclinical Alzheimer's disease: A systematic review and meta-analysis.

  2025cites this paper
• Person‐centered care at population scale: The Swedish registry for behavioral and psychological symptoms of dementia

  2025cites this paper
• In vivo-measured Lewy body pathology is associated with neuropsychiatric symptoms across the Alzheimer's disease continuum.

  2025cites this paper
• Apathy, depression, and dementia risk in older adults: A global collaborative study

  2025cites this paper
• Erotomania in Alzheimer’s Dementia: A Rare but Clinically Important Association

  2025cites this paper
• Alzheimer disease seen through the lens of sex and gender

  2025cites this paper
• Development and Validation of the DA3 Scale for Assessing Depression, Anxiety, and Apathy in Older Adults.

  2025cites this paper
• Specific cognitive impairment predicts the neuropsychiatric symptoms in patient with mild cognitive impairment

  2025cites this paper
• Weighted Blankets for Agitation in Hospitalized Patients with Dementia: Protocol for a Randomized Controlled Trial

  2025cites this paper
• Diagnosis and Management of Dementia for the Nephrology Clinician.

  2025cites this paper
• Tract-specific white matter hyperintensities and neuropsychiatric syndromes: a multicentre memory clinic study

  2025cites this paper
• Co-occurrence of neuropsychiatric symptoms in ADAMS, ADNI and NACC studies as assessed by Neuropsychiatric Inventory

  2025cites this paper
• Exome sequencing reveals a rare damaging variant in GRIN2C in familial late-onset Alzheimer's disease

  2025cites this paper
• Behavioral and Psychological Symptoms (BPSD) in Alzheimer's Disease (AD): Development and Treatment.

  2025cites this paper
• Synaptic and synchronic impairments in subcortical brain regions associated with early non-cognitive dysfunction in Alzheimer’s disease

  2025cites this paper
• The Implementation of Infant Anoesis and Adult Autonoesis in the Retrogenesis and Staging System of the Neurocognitive Disorders: A Proposal for a Multidimensional Person-Centered Model

  2025cites this paper
• Who are the best informants of neuropsychiatric symptoms across the continuum of cognitive decline?

  2025cites this paper
• Apathy in Dementia: A Pilot Study Providing Insights from Neuropsychiatric and Radiological Perspectives

  2025cites this paper
• Efficacy and Safety of Bilateral Deep Brain Stimulation (DBS) for Severe Alzheimer's Disease: A Comparative Analysis of Fornix Versus Basal Ganglia of Meynert

  2025cites this paper
• The Canadian Coalition for Seniors’ Mental Health Canadian Clinical Practice Guidelines for Assessing and Managing Behavioural and Psychological Symptoms of Dementia (BPSD)

  2025cites this paper
• ADNet: deep learning based model for Alzheimer’s disease classification

  2025cites this paper
• Chronic stress leads to earlier cognitive decline in an Alzheimer's mouse model: The role of neuroinflammation and TrkB.

  2025influential citation
• Risk of Antipsychotic Initiation Among Older Dementia Patients Initiating Cholinesterase Inhibitors

  2025cites this paper
• Intersection of pain and behavioural and psychological symptoms of dementia in Alzheimer's disease

  2025cites this paper
• Neurobiological effects of music-making interventions for older adults: a systematic review

  2025cites this paper
• Impact of obesity on neuropsychiatric symptoms in Alzheimer's disease: Insights from the ADNI cohort

  2025cites this paper
• Clinical Evolution of Neuropsychiatric Symptoms in Alzheimer's Disease and Dementia With Lewy Bodies in a Post‐Mortem Cohort

  2025cites this paper
• Do changed behaviors predict cognitive decline in a community sample?

  2025cites this paper
• Targeting the chemokine-microglia nexus: A novel strategy for modulating neuroinflammation in Alzheimer's disease

  2025cites this paper
• A Descriptive Statistical Analysis of Neuropsychiatric Symptom Pair Prevalence

  2025cites this paper
• Non-pharmacological Interventions to Reduce Behavioral and Psychological Symptoms of Dementia

  2025cites this paper
• Does Retirement Improve Cognitive Functioning? Causal Evidence From Vietnam.

  2025cites this paper
• Impaired insulin receptor function alters psychiatric behaviors without affecting circadian rhythms in a mouse model of Alzheimer's disease

  2025cites this paper
• Neuropsychiatric Symptoms and White Matter Hyperintensities in Older Cognitively Unimpaired Men Versus Women

  2025cites this paper
• The Impact of Nondepressive Neuropsychiatric Symptoms on Mortality in Dementia: A Systematic Review and Meta-analysis.

  2025cites this paper
• Clinical trials for neuropsychiatric syndromes in major and mild neurocognitive disorders: A CONSORT-based approach

  2025cites this paper
• Creating harmony at home via environmental cueing: A feasibility trial of a non‐pharmacological intervention for rural caregivers of persons with dementia

  2025cites this paper
• Protective Potential of Satureja montana-Derived Polyphenols in Stress-Related Central Nervous System Disorders, Including Dementia

  2025influential citation
• The Relationship of Alzheimer's Disease and Related Dementias Blood‐Based Biomarkers and Informant‐Reported Neuropsychiatric Symptoms Differs by Informant Type in Older Adults Without Dementia

  2025cites this paper
• Mild Behavioral Impairment: A Population-Based Study

  2025cites this paper
• Quality indicators for behavioral and psychological symptoms of dementia in acute care: a scoping review

  2025cites this paper
• Psychometric evaluation of the Persian version of the mild behavioral impairment checklist (MBI-C) among the older population

  2025cites this paper
• Increased granulovacuolar degeneration in the thalamus and higher neurofibrillary tangle Braak stages in bipolar disorder

  2025cites this paper
• Social Interaction Deficits and Anxiety-like Behavioral Changes in the TgF344-AD Rat Model of Alzheimer's Disease.

  2025cites this paper
• Co‐pathology in Alzheimer's disease and Lewy body disease and its association with neuropsychiatric symptoms

  2025cites this paper
• Mortality and institutionalization of patients with dementia treated in primary care: influence of neuropsychiatric symptoms (NeDEM project)

  2025cites this paper
• Editorial: Neuropsychiatric symptoms and cognitive impairment

  2025cites this paper
• Natural Evolution and Heterogeneity of Neuropsychiatric Symptoms Across Neurocognitive Disorders: A Systematic Review and Meta‐Analysis of Longitudinal Studies

  2025cites this paper
• Affective Neuropsychiatric Symptom Metrics in the National Alzheimer’s Coordinating Center Dataset

  2025cites this paper
• Effectiveness of cognitive stimulation for individuals with mild cognitive impairment: a systematic review and meta-analysis

  2025cites this paper
• Network analysis of the relationships among activities of daily living disability, cognitive impairment, and depression in Chinese older adults

  2025cites this paper
• Association between anosognosia and neuropsychiatric symptoms in Alzheimer’s disease dementia patients

  2025cites this paper
• The Relationship Between Brain Structure and Neuropsychiatric Symptoms in Patients With Mild Cognitive Impairment and Alzheimer's Dementia

  2025cites this paper
• Mild Behavioral Impairment and Cerebrovascular Profiles Are Associated with Early Cognitive Impairment in a Community-Based Southeast Asian Cohort

  2024cites this paper
• Depression and Agitation Factors Are Related to Regional Brain Atrophy and Faster Longitudinal Cognitive Decline in Mild Cognitive Impairment

  2024cites this paper